The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions

Documenti analoghi

• Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group‐Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future
  di: Rajesh Krishna, et al.
  Pubblicazione: (2024)
• Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
  di: Helga Gardarsdottir, et al.
  Pubblicazione: (2025)
• Capability Development in the European Medicines Regulatory Network—A European Learning Needs Analysis and Survey Study
  di: Naomi Beard, et al.
  Pubblicazione: (2025)
• Regulatory Issues of Platform Trials: Learnings from EU‐PEARL
  di: Quynh Lan Nguyen, et al.
  Pubblicazione: (2024)
• Roles and Impacts of Integrative Medical Interventions in Central Nervous System Tumor Treatment: Multi‐Technology Convergence and the Paradigm Shift Toward Functional Reconstruction
  di: Junda Lai, et al.
  Pubblicazione: (2025)